|
2006 Journal Article Combination antithymocyte globulin and soluble TNF alpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host diseaseKennedy, GA, Butler, J, Western, R, Morton, J, Durrant, S and Hill, GR (2006). Combination antithymocyte globulin and soluble TNF alpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplantation, 37 (12), 1143-1147. doi: 10.1038/sj.bmt.1705380 |
|
2006 Journal Article Stem cell mobilization with G-CSF analogs: A rational approach to separate GVHD and GVL?Morris, Edward S., MacDonald, Kelli P. A. and Hill, Geoffrey R. (2006). Stem cell mobilization with G-CSF analogs: A rational approach to separate GVHD and GVL?. Blood, 107 (9), 3430-3435. doi: 10.1182/blood-2005-10-4299 |
|
2005 Journal Article NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogsMorris, Edward S., MacDonald, Kelli P. A., Rowe, Vanessa, Banovic, Tatjana, Kuns, Rachel D., Don, Alistair L. J., Bofinger, Helen M., Burman, Angela C., Olver, Stuart D., Kienzle, Norbert, Porcelli, Steven A., Pellicci, Daniel G., Godfrey, Dale I., Smyth, Mark J. and Hill, Geoffrey R. (2005). NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. Journal of Clinical Investigation, 115 (11), 3093-3103. doi: 10.1172/JCI25249 |
|
2005 Journal Article TGF-beta in allogeneic stem cell transplantation: friend or foe?Banovic, T, MacDonald, KPA, Morris, ES, Rowe, V, Kuns, R, Don, A, Kelly, J, Ledbetter, S, Clouston, AD and Hill, GR (2005). TGF-beta in allogeneic stem cell transplantation: friend or foe?. Blood, 106 (6), 2206-2214. doi: 10.1182/blood-2005-01-0062. |
|
2005 Journal Article A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's diseaseTey, S ., Butler, J ., Durrant, S., Hill, G., Morton, J., Kennedy, G. and Kennedy, G. (2005). A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplantation, 36 (6), 553-554. doi: 10.1038/sj.bmt.1705044 |
|
2005 Journal Article The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansionMacDonald, Kelli P. A., Rowe, Vanessa, Bofinger, Helen. M., Thomas, Ranjeny, Sasmono, Tedjo, Hume, David A. and Hill, Geoffrey R. (2005). The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. Journal of Immunology, 175 (3), 1399-1405. doi: 10.4049/jimmunol.175.3.1399 |
|
2005 Journal Article Host gamma delta T cells: an innate bridge to the epithelial targets of GVHD?Hill, GR (2005). Host gamma delta T cells: an innate bridge to the epithelial targets of GVHD?. Blood, 106 (2), 393-394. doi: 10.1182/blood-2005-04-1616 |
|
2005 Journal Article Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patientsHall, P, Kennedy, G, Morton, J, Hill, GR and Durrant, S (2005). Twenty-four hour continuous infusion of amphotericin B for the treatment of suspected or proven fungal infection in haematology patients. Internal Medicine Journal, 35 (6), 374-374. doi: 10.1111/j.1445-5994.2005.00847.x |
|
2005 Journal Article Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator productionJohnson, BJ, Le, TTT, Dobbin, CA, Banovic, T, Howard, CB, Flores, FDL, Vanags, D, Naylor, DJ, Hill, GR and Suhrbier, A (2005). Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. Journal of Biological Chemistry, 280 (6), 4037-4047. doi: 10.1074/jbc.M411569200 |
|
2005 Journal Article Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cellsMacDonald, Kelli P. A., Rowe, Vanessa, Clouston, Andrew D., Welply, Joseph K., Kuns, Rachel D., Ferrara, James L. M., Thomas, Ranjeny and Hill, Geoffrey R. (2005). Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. Journal of Immunology, 174 (4), 1841-1850. doi: 10.4049/jimmunol.174.4.1841 |
|
2005 Journal Article Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationKennedy, GA, Butler, J, Western, R, Morton, J, Hill, G and Durrant, S (2005). Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia, 19 (2), 317-318. doi: 10.1038/sj.leu.2403549 |
|
2004 Journal Article Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation toleranceMorris, ES, MacDonald, KPA, Rowe, V, Johnson, DH, Banovic, T, Clouston, AD and Hill, GR (2004). Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood, 103 (9), 3573-3581. doi: 10.1182/blood-2003-08-2864 |
|
2004 Journal Article Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: The role of donor T-cell dose and differentiationMacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Johnson, Diana, Morris, Edward S., Clouston, Andrew D., Ferrara, James L. M. and Hill, Geoffrey R. (2004). Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: The role of donor T-cell dose and differentiation. Biology of Blood And Marrow Transplantation, 10 (6), 373-385. doi: 10.1016/j.bbmt.2004.02.002 |
|
2003 Journal Article Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expressionVuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003). Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 (6), 2314-2317. doi: 10.1182/blood-2002-03-0973 |
|
2003 Journal Article Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationMacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Thomas, Ranjeny, Clouston, Andrew D., Welply, Joseph K., Hart, Derek N. J., Ferrara, James L. M. and Hill, Geoffrey R. (2003). Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood, 101 (5), 2033-2042. doi: 10.1182/blood-2002-05-1529 |
|
2002 Journal Article Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxisWellwood, J, Taylor, K, Wright, S, Bentley, M, Hill, G, Phan, H, Norris, D and Livsey, R (2002). Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis - A missed opportunity for induction CNS prophylaxis. Leukemia & Lymphoma, 43 (4), 893-896. doi: 10.1080/10428190290017060 |
|
2002 Journal Article Keratinocyte Growth factor (KGF) in hematology and oncologyMacDonald, KPA and Hill, GR (2002). Keratinocyte Growth factor (KGF) in hematology and oncology. Current Pharmaceutical Design, 8 (5), 395-403. doi: 10.2174/1381612023396104 |
|
2001 Journal Article LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationCooke, KR, Gerbitz, A, Crawford, JM, Teshima, T, Hill, GR, Tesolin, A, Rossignol, DP and Ferrara, JLM (2001). LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. Journal of Clinical Investigation, 107 (12), 1581-1589. doi: 10.1172/JCI12156 |
|
2001 Journal Article Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantationTeshima, T, Mach, N, Hill, GR, Pan, LY, Gillessen, S, Dranoff, G and Ferrara, JLM (2001). Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer Research, 61 (1), 162-171. |
|
2000 Journal Article Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammationCooke, KR, Hill, GR, Gerbitz, A, Kobzik, L, Martin, TR, Crawford, JM, Brewer, JP and Ferrara, JLM (2000). Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation. Journal of Immunology, 165 (11), 6612-6619. doi: 10.4049/jimmunol.165.11.6612 |
